Olink® Target 96 Oncology II by Olink Proteomics

Manufacturer Olink Proteomics  |   Model: 95700
4.3
/
5.0
  |  1 reviews
Towards a better understanding of cancer and personalized medicine.


Olink® Target 96 Oncology II by Olink Proteomics product image
Olink® Target 96 Oncology II
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 4.3
1 Scientist has reviewed this product

4 out of 5
Ease of use
5 out of 5
After sales service
4 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2019

  • Organization: Bristol Myers Squibb



  • Ease of use
    4 out of 5
    After sales service
    5 out of 5
    Value for money
    4 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
2022 will be a great year for biomarker discovery.
Rating: 4.3

  • Application Area: Biomarker discovery

"This is a relatively new capability available to the consumer. From a very low volume of sample, we can analyze the relative prevalence of 90 proteins. The assay is sensitive and accurate."

Review date: 01 Apr 2022 | Olink® Target 96 Oncology II

Our Oncology II panel provides a high-throughput, multiplex immunoassay enabling analysis of 92 cancer-related protein biomarkers across 96 samples simultaneously. This high level of multiplexing is achieved without any compromise on data quality, thanks to our proprietary Proximity Extension Assay (PEA) technology. 

Together with our ONCOLOGY III panel, this represents the most extensive solution available for proteins associated with cancer and oncology-related biological processes, enabling investigation of protein signatures with high efficiency and robustness and accelerates the speed of finding new and relevant human protein biomarkers related to oncology. The panel is compiled to detect a selection of already established as well as exploratory biomarkers within the oncology research field. The content of the panel has been designed in close collaboration with experts within the field, and it is well suited to discerning protein profiles in clinically relevant samples.

  • High quality data that you can trust
  • The rapid high throughput analysis that your studies deserve
  • The most effective use of your precious samples (1 µL blood to measure 92 proteins)

The panel is available via fee-for-service analysis, or as a reagent kit (requires a Fludigm® Biomark qPCR instrument to run)